Results 181 to 190 of about 1,421,169 (298)

Can Dietary Supplements Improve Inflammatory Biomarkers and Clinical Symptoms in Migraine? A Narrative Review. [PDF]

Int J Prev Med
Nohegari M, Vafa M.
europepmc   +1 more source

Depressive and Anxiety Symptoms in Vestibular Migraine and Probable Vestibular Migraine

Clinical Otolaryngology, EarlyView.
ABSTRACT Introduction It has been previously reported that patients with vestibular migraine (VM) are more prone to anxiety and depressive symptoms. However, the association between the pathophysiology of VM and anxiety and depressive symptoms is still unclear.
Chisato Fujimoto, Naoko Ogata, Kento Koda, Kentaro Ichijo, Mineko Oka, Makoto Kinoshita, Kenji Kondo   +6 more
wiley   +1 more source

Vertigo and dizziness syndromes in children and adolescents: Clinical presentation and diagnostic pathway

Developmental Medicine &Child Neurology, EarlyView.
This study characterized 519 children and adolescents with vertigo using clinical, diagnostic, imaging, quality‐of‐life, and demographic data, identifying vestibular migraine as the most frequent diagnosis, followed by functional dizziness and recurrent vertigo of childhood.
Doreen Huppert, Ralf Strobl, Andreas Zwergal, Florian Heinen, Michaela V. Bonfert, Marius Näher, Anna Huppert, Filipp M. Filippopulos   +7 more
wiley   +1 more source

Exploring Proximal and Distal Ultrasound-Guided Greater Occipital Nerve Block Approaches in Migraine: A Systematic Review and Meta-Analysis. [PDF]

Pain Pract
Sabet H, Samir A, Lashin B, Abbas A, Ramadan S, El-Moslemani M, Younis AF, Yousef O, Rouby RA, Abd-Elsayed A.   +9 more
europepmc   +1 more source

Physiotherapy Interventions for Migraine: A Systematic Review of Clinical Trials. [PDF]

Clin Pract
Strachanowska HM, Kaczmarska MA, Robakowska M, Brancewicz M.   +3 more
europepmc   +1 more source

Neuropsychiatric Outcomes Associated With GLP‐1 Receptor Agonist Use in Medicare Beneficiaries With Type 2 Diabetes: Variation by Treatment Pattern and Obesity Status

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Glucagon‐like peptide‐1 (GLP‐1) receptors are expressed in brain regions governing mood, reward and stress, yet the neuropsychiatric effects of GLP‐1 receptor agonist (GLP‐1 RA) therapy remain poorly characterized. We estimated associations between GLP‐1 RA use and neuropsychiatric disorders and variation by obesity status and treatment ...
Seo Hyon Baik, Fitsum Baye, Haotian Xian, Kin Wah Fung, Clement J. McDonald   +4 more
wiley   +1 more source

Retinal optical coherence tomography angiography findings in the new- onset migraine patients: a prospective case-control study. [PDF]

BMC Ophthalmol
Mahmoud H, Tohamy D, Amin AE, Saman ISE, Korishy MSH.   +4 more
europepmc   +1 more source

Cognitive and emotional mechanisms underlying migraine quality of life

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective This study was conducted to examine how migraine‐related illness perceptions, shame, and psychological distress are associated with migraine‐specific quality of life, and to test a serial mediation model in which illness perceptions relate to quality of life via shame and psychological distress.
Shiri Shinan‐Altman, Yaira Hamama‐Raz   +1 more
wiley   +1 more source

Real‐world outcomes of zavegepant use in a tertiary care setting using the Migraine Treatment Optimization Questionnaire‐5

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background The introduction of calcitonin gene‐related peptide antagonists has transformed migraine care. Zavegepant, a third‐generation intranasal gepant, offers a nonoral treatment option for acute migraine. Although clinical trials support its efficacy and safety, real‐world data are limited.
Eric Dunn, Bradley Ong, Harpreet Kaur, Roman Popov, Claire Sonneborn, Aarushi Suneja   +5 more
wiley   +1 more source

Botulinum Toxin Therapy for Diseases in the Oral and Maxillofacial Regions: Current Evidence and Future Perspectives. [PDF]

Toxins (Basel)
Yoshida K.
europepmc   +1 more source